![Richard Ono](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Ono
Presidente presso
LIPOCINE INC.
Patrimonio netto: 1 870 $ in data 31/05/2026
Profilo
Richard Dana Ono was the founder of IntraImmune Therapies, Inc., founded in 1995, where the title held was President & Chief Executive Officer from 1995 to 2000.
Dr. Ono is also the founder of VIMAC Milestone Medica Fund LP..
Dr. Ono is currently Chairman at Lipocine, Inc. since 2026, Managing Director at VIMAC Ventures LLC, Founding Director at Massachusetts Biotechnology Council, and Member at The Explorers Club.
Former positions include Director at Mimetogen Pharmaceuticals, Inc., Independent Director at Inhibitor Therapeutics, Inc. from 2014 to 2022, and Trustee at The Marine Biological Laboratory.
Education includes graduate and doctorate degrees from Harvard University and an undergraduate degree from The Johns Hopkins University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
LIPOCINE INC 0,01% | 03/06/2026 | 831 ( 0,01% ) | 1 870 $ | 31/05/2026 |
Posizioni attive di Richard Ono
| Società | Posizione | Inizio |
|---|---|---|
| LIPOCINE INC. | Presidente | 20/04/2026 |
VIMAC Ventures LLC
 VIMAC Ventures LLC Investment ManagersFinance VIMAC Ventures invests primarily in emerging growth companies located in the northeastern region of the United States and Canada. The firm targets companies operating in the fields of information technology, communications, internet technologies & life sciences. It provides financing for seed and early-stage capital requirements with an investment size ranging from USD 5 – 15 million. It acts as lead or co-lead investor. | Investitore di Private Equity | - |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Direttore/Membro del Consiglio | - |
The Explorers Club
 The Explorers Club Miscellaneous Commercial ServicesCommercial Services Engages in promoting the scientific exploration of land, sea, air and space by research and education in the physical, natural and biological sciences | Corporate Officer/Principal | - |
Precedenti posizioni note di Richard Ono
| Società | Posizione | Fine |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Direttore/Membro del Consiglio | 13/12/2022 |
IntraImmune Therapies, Inc.
 IntraImmune Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies that allow antibodies to gain access to intracellular targets | Amministratore Delegato | 01/01/2000 |
VIMAC Milestone Medica Fund LP
 VIMAC Milestone Medica Fund LP Investment ManagersFinance Acts as Venture Capital Fund | Fondatore | - |
Mimetogen Pharmaceuticals, Inc.
 Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptidomimetic small molecule drugs against glaucoma and cancer | Direttore/Membro del Consiglio | - |
The Marine Biological Laboratory
 The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services Provides research and educational services | Direttore/Membro del Consiglio | - |
Formazione di Richard Ono
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
67
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IntraImmune Therapies, Inc.
IntraImmune Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies that allow antibodies to gain access to intracellular targets | Commercial Services |
VIMAC Ventures LLC
VIMAC Ventures LLC Investment ManagersFinance VIMAC Ventures invests primarily in emerging growth companies located in the northeastern region of the United States and Canada. The firm targets companies operating in the fields of information technology, communications, internet technologies & life sciences. It provides financing for seed and early-stage capital requirements with an investment size ranging from USD 5 – 15 million. It acts as lead or co-lead investor. | Finance |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
The Explorers Club
The Explorers Club Miscellaneous Commercial ServicesCommercial Services Engages in promoting the scientific exploration of land, sea, air and space by research and education in the physical, natural and biological sciences | Commercial Services |
VIMAC Milestone Medica Fund LP
VIMAC Milestone Medica Fund LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
The Marine Biological Laboratory
The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services Provides research and educational services | Commercial Services |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptidomimetic small molecule drugs against glaucoma and cancer | Health Technology |
Lipocine, Inc.
 Lipocine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in research and development for the delivery of drugs | Health Technology |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
